This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, November 2, 2009
Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
Oct 30, 2009 - Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR® (fenofibrate) tablets, 48 mg and 145 mg.
No comments:
Post a Comment